Skip to main content

Want a detailed portfolio tracker?

LB Pharmaceuticals (LBRX) P/E (2025 - 2026)

LB Pharmaceuticals (LBRX) P/E from Sep 30, 2025 to Jul 21, 2026. The TTM LB Pharmaceuticals (LBRX) P/E is -25.67. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of LB Pharmaceuticals (LBRX)

YearP/EChange
2026-25.67-31.48%
2025-37.47N/A

Comparison LB Pharmaceuticals (LBRX) P/E with competitors

LB Pharmaceuticals (LBRX) P/E is -25.67.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.29%
FGENFibroGen Inc0.24-100.93%
CHRSCoherus Biosciences Inc0.85-103.30%
FBIOFortress Biotech Inc0.95-103.70%
ORMPOramed Pharmaceuticals Inc1.50-105.85%
AGENAgenus Inc3.01-111.72%
INVAInnoviva Inc3.15-112.28%
VXRTVaxart Inc3.55-113.83%
CRMDCorMedix Inc3.63-114.13%
CVACCureVac N.V.4.45-117.31%
GLPGGalapagos NV4.86-118.92%
SRPTSarepta Therapeutics Inc4.88-119.01%
ABEOAbeona Therapeutics Inc5.39-120.98%
ABUSArbutus Biopharma Corp5.60-121.79%
ZVRAZevra Therapeutics Inc5.89-122.93%
SPROSpero Therapeutics Inc6.23-124.26%
CGENCompugen Ltd6.31-124.59%
RIGLRigel Pharmaceuticals6.87-126.76%
SLXNSilexion Therapeutics Corp7.30-128.42%
OMEROmeros Corporation9.26-136.06%
AUPHAurinia Pharmaceuticals Inc9.58-137.33%
PLXProtalix BioTherapeutics Inc10.89-142.42%
ACADAcadia Pharmaceuticals Inc11.73-145.68%
TBPHTheravance Biopharma Inc12.26-147.76%
ADMAAdma Biologics Inc12.42-148.37%
HRMYHarmony Biosciences Holdings Inc13.82-153.83%
SABSSAB Biotherapeutics Inc14.14-155.06%
NAGENiagen Bioscience Inc14.82-157.71%
INCYIncyte Corp15.82-161.62%
REGNRegeneron Pharmaceuticals Inc15.86-161.76%
PBYIPuma Biotechnology Inc17.32-167.44%
CPRXCatalyst Pharmaceuticals Inc17.44-167.92%
EXELExelixis Inc17.54-168.31%
TGTXTG Therapeutics Inc18.97-173.87%
MDXGMimedx Group Inc20.55-180.05%
XOMAXOMA Royalty Corp22.87-189.09%
ARGXArgen X SE24.30-194.64%
CTMXCytomX Therapeutics Inc24.82-196.67%
XOMAOXOMA Royalty Corp25.34-198.71%
HALOHalozyme Therapeutics Inc25.62-199.80%
XOMAPXOMA Royalty Corp25.67-199.98%
VRTXVertex Pharmaceuticals Inc27.99-209.03%
RPRXRoyalty Pharma plc - Class A28.69-211.73%
SLNOSoleno Therapeutics Inc29.02-213.01%
ASNDAscendis Pharma A/S30.09-217.18%
LGNDLigand Pharmaceuticals Inc - Class B37.91-247.66%
APLSApellis Pharmaceuticals Inc39.02-251.98%
BMRNBiomarin Pharmaceutical Inc42.21-264.41%
KRYSKrystal Biotech Inc45.34-276.61%
ONCBeiGene Ltd69.54-370.85%
PHARPharming Group N.V.75.03-392.21%
TECHBio-Techne Corp101.96-497.11%
VCELVericel Corp109.92-528.13%
ALNYAlnylam Pharmaceuticals Inc117.96-559.46%
GMABGenmab140.29-646.41%
TLXTelix Pharmaceuticals Ltd162.15-731.56%
CORTCorcept Therapeutics Inc212.86-929.05%